Cryton Biosciences
PrivateLast Round
Seed
Aug 1, 2025
Total Funding Raised
$200,000
Company Overview
Cryton Biosciences operates in Healthcare & Life Sciences and is based in Austin, Minnesota. Its latest recorded funding round was a Seed round in August 2025.
Cryton Biosciences is a biotechnology company developing a dual-action oral drug designed to starve tumors and prime the immune system to kill cancer by targeting mitochondrial metabolism.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cryton Biosciences Comparables
Compare Cryton Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mito BioPharma | 81% | |
| Madera Therapeutics | 81% | |
| Imel Biotherapeutics | 69% |
For institutional investors. Book with your work email.
Cryton Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 1, 2025 | ||||
| Accelerator | Aug 1, 2025 |
For institutional investors. Book with your work email.
Cryton Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Right Side Capital Management | Seed, Accelerator |
| gener8tor | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2025
$100K round led by Right Side Capital Management
- Aug 1, 2025
$100K round from Right Side Capital Management and gener8tor
For institutional investors. Book with your work email.
Cryton Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cryton Biosciences's valuation, stock price, and market status.
Is Cryton Biosciences a public or private company?
Cryton Biosciences is a private company.
What is the current stock price of Cryton Biosciences?
Cryton Biosciences is a private company, so its shares have no public market price. Caplight tracks Cryton Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cryton Biosciences worth (valuation)?
Valuation information for Cryton Biosciences is not publicly available.
Can I buy Cryton Biosciences stock?
Cryton Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cryton Biosciences's last funding round?
Cryton Biosciences's most recent funding round was Seed on August 1, 2025.
Who are the main investors in Cryton Biosciences?
Key investors in Cryton Biosciences include Right Side Capital Management, gener8tor.
Will Cryton Biosciences IPO soon?
No public IPO plans have been announced for Cryton Biosciences.
How can I track Cryton Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Cryton Biosciences's shares on secondary markets.